SA Entreparticuliers.com (EPA:ALENT)

Theseus Pharmaceuticals Income Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	0.62	0.75	0.77	0.94	0.56
Revenue Growth (YoY)	-17.39%	-2.37%	-18.06%	68.50%	17.72%
Cost of Revenue	0.2	0.2	0.18	0.67	0.13
Gross Profit	0.42	0.55	0.59	0.27	0.43
Selling, General & Admin	0.28	0.4	0.44	0.06	0.36
Other Operating Expenses	-0.03	-0.04	-0.01	-0.02	-0.15
Operating Expenses	0.27	0.39	0.46	0.07	0.23
Operating Income	0.15	0.16	0.13	0.2	0.21
Interest Expense	-	-	-	-0	-
Other Non Operating Income (Expenses)	-0.01	-0.04	0	0.03	-0.03
EBT Excluding Unusual Items	0.14	0.13	0.13	0.23	0.18
Gain (Loss) on Sale of Investments	-0.02	-0.03	-0.06	0.11	-0
Asset Writedown	-	-0.22	-	-	-
Other Unusual Items	0.01	0.01	-0.01	-0.04	0.02
Pretax Income	0.13	-0.11	0.06	0.3	0.2
Income Tax Expense	-0	-0	-0	-	0
Net Income	0.13	-0.11	0.07	0.3	0.2
Net Income to Common	0.13	-0.11	0.07	0.3	0.2
Net Income Growth	-	-	-77.39%	48.35%	729.69%
Shares Outstanding (Basic)	4	4	4	-	4
Shares Outstanding (Diluted)	4	4	4	-	4
EPS (Basic)	0.04	-0.03	0.02	-	0.06
EPS (Diluted)	0.04	-0.03	0.02	-	0.06
EPS Growth	-	-	-	-	729.72%
Free Cash Flow	0.16	0.08	-0.06	-	-
Free Cash Flow Per Share	0.05	0.02	-0.02	-	-
Gross Margin	67.56%	73.11%	76.80%	28.50%	77.01%
Operating Margin	23.83%	21.77%	17.33%	21.32%	36.69%
Profit Margin	21.42%	-14.47%	8.65%	31.36%	35.62%
Free Cash Flow Margin	25.87%	10.16%	-7.32%	-	-
EBITDA	0.15	0.4	0.16	0.23	0.24
EBITDA Margin	23.94%	52.74%	20.91%	24.24%	43.19%
D&A For EBITDA	0	0.23	0.03	0.03	0.04
EBIT	0.15	0.16	0.13	0.2	0.21
EBIT Margin	23.83%	21.77%	17.33%	21.32%	36.69%
Effective Tax Rate	-	-	-	-	0.09%
Revenue as Reported	0.66	0.8	0.79	0.99	0.71
Advertising Expenses	-	-	-	0	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.